Доцент д-р Фам Кам Фуонг: Содействие международному сотрудничеству в целях улучшения лечения рака во Вьетнаме. vietnam.vn
Real-World Data Reveal a Sobering Gap in Lung Cancer Care After Osimertinib Fails Bioengineer.org
One of the major challenges in treating the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance to treatment. In a recent study, Boston Children's Hospital researchers and colleagues discovered a new driver of resistance, pointing to a way to detect resistant cancer…
For years, TFEB has been regarded as one of the most promising therapeutic targets for restoring the cell's ability to clear and recycle waste. Yet turning that promise into therapies has proved difficult because TFEB itself is hard to target with drugs. Now, a study published in Nature by scientists at the Telethon…
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working The New York Times
Brian Mazzarella, MD, reviews early data on water vapor therapy for localized prostate cancer Urology Times